Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

LS ARK Genomic Revolution Tracker ETP Securities XS2399368062

1.95
EUR
-0.01
EUR
-0.57%
11:16:59
NAV

Nettoinventarwert (NAV)

2.03 USD -0.02 USD -0.88 %
Vortag 2.05 USD Datum 26.11.2024

LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX
LS ARK Genomic Revolution Tracker ETP Securities Chart

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stellar ETP CH1109575535 345.75%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Sui Staking ETP CH1360612159 217.90%
21Shares Cardano ETP CH1102728750 142.08%
21Shares Ripple XRP ETP CH0454664043 125.82%
21Shares Fantom ETP CH1168929078 105.42%
21Shares Injective Staking ETP CH1360612134 18.63%
21Shares Immutable ETP CH1360612142 8.49%
Name ISIN Performance
21Shares Stellar ETP CH1109575535 296.63%
21Shares Ripple XRP ETP CH0454664043 149.01%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Cardano ETP CH1102728750 94.85%
21Shares Aave ETP CH1135202120 71.46%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 298.88%
21Shares Stellar ETP CH1109575535 263.93%
21Shares Fantom ETP CH1168929078 225.18%
21Shares Binance BNB ETP CH0496454155 154.74%
21Shares Staking Basket Index ETP CH1210548892 150.38%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’568.01%
21Shares Bitcoin Core ETP CH1199067674 460.26%
21Shares Bitcoin ETP CH0454664001 446.11%
21Shares Fantom ETP CH1168929078 432.16%
21Shares Stellar ETP CH1109575535 368.46%

Fundamentaldaten

Valor
ISIN XS2399368062
Emittent Leverage Shares PLC
Aufgelegt in Ireland
Auflagedatum 10.12.2021
Kategorie Trading - Leveraged/Inverse Aktien
Währung USD
Volumen 465’178.89
Depotbank
Geschäftsjahresende
Berichtsstand 27.11.2024

Anlagepolitik

So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.

ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities

Performance 1 Jahr
-10.82
Performance 2 Jahre
-21.62
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -